The following is from AI:
Chronic infections, chronic inflammation, and other conditions causing “anemia of chronic disease” (ACD) lead to pure microcytic anemia (MCV < 80 fL, MCH < 27 pg, with normal or only mildly reduced MCHC) not because the body is truly iron-deficient, but due to impaired iron utilization and “malicious sequestration” of iron.
Medically, this process is primarily governed by a central regulatory hormone—hepcidin. The specific pathogenic sequence unfolds as follows:
1. Core Mechanism: Abnormal Activation of Hepcidin
During chronic infection or inflammation, the immune system releases large amounts of pro-inflammatory cytokines (e.g., interleukin-6 [IL-6], tumor necrosis factor [TNF-α]). These cytokines stimulate the liver to synthesize and secrete hepcidin in excess.
Hepcidin acts as the “master switch” of systemic iron metabolism; its surge causes two critical consequences:
- Suppression of intestinal iron absorption: Hepcidin degrades ferroportin—the iron exporter on the surface of duodenal enterocytes—thereby blocking dietary iron uptake from the gut.
- Sequestration of iron within the monocyte-macrophage system: Iron released from senescent red blood cells is normally recycled by macrophages and re-released into circulation. However, hepcidin “locks the doors” of macrophages, trapping iron inside macrophages and hepatocytes (manifesting as elevated ferritin) and preventing its release into the bloodstream.
2. Bone Marrow “Iron Deficiency”: Red Blood Cells Become Progressively Smaller
Due to the sharp drop in circulating (serum) iron, the bone marrow—which produces red blood cells—lacks sufficient iron to synthesize hemoglobin.
Red blood cell development and division in the bone marrow operates via a feedback mechanism: as long as intracellular hemoglobin concentration has not reached saturation, erythroblasts tend to undergo one additional mitotic division.
Because iron availability is limited, hemoglobin synthesis proceeds extremely slowly. To achieve adequate hemoglobin concentration per cell, erythroblasts undergo an extra division—resulting in mature red blood cells released into peripheral blood that are significantly smaller in volume (reduced MCV) and contain less total hemoglobin per cell (reduced MCH).
3. Why Is It “Pure” Microcytosis? (Why Does MCHC Remain Largely Normal?)
In early- to mid-stage anemia of chronic disease, the presentation is typically normocytic or purely microcytic, rather than the “microcytic hypochromic” pattern seen in severe iron deficiency anemia (where MCHC is markedly decreased).
This is because, in ACD, the reduction in red blood cell volume (MCV) and the decrease in hemoglobin content per cell (MCH) occur in proportionate, parallel fashion. Although the cells shrink, the density (concentration) of hemoglobin within them—the MCHC—remains relatively preserved within the normal range (320–360 g/L).
4. Additional Contributing Factors
Beyond impaired iron utilization, chronic infection exacerbates anemia through two further pathways:
- Blunted erythropoietin (EPO) response: Pro-inflammatory cytokines suppress renal EPO production and/or reduce bone marrow sensitivity to EPO, dampening erythropoietic drive.
- Reduced red blood cell survival: Activated macrophages in inflammatory states exhibit heightened phagocytic activity and may prematurely engulf and destroy otherwise healthy, non-senescent red blood cells.
Summary
The fundamental cause of pure microcytic anemia in chronic infection is: iron is present in the body—but it is “locked away in the warehouse” (macrophages) by inflammatory mediators and thus unavailable to the bone marrow, which consequently manufactures a cohort of smaller-than-normal red blood cells due to functional iron deficiency.
A classic laboratory hallmark accompanying this anemia is: low serum iron, yet normal or even elevated stored iron (serum ferritin).